Heart Rate Variability Biofeedback for Female Sexual Arousal Disorder
Launched by UNIVERSITY OF TEXAS AT AUSTIN · Nov 4, 2016
Trial Information
Current as of April 29, 2025
Completed
Keywords
ClinConnect Summary
Women who meet ICD-10-CM diagnostic criteria for FSAD will be recruited and randomized into one of three conditions, HRV biofeedback (n = 25), HRV biofeedback plus autogenic training (n = 25), or wait-list control (n = 15). All participants will complete a baseline assessment, during which their resting state HRV and vaginal pulse amplitude (VPA) will be measured. The participants in the two biofeedback conditions will receive training in HRV biofeedback from the experimenter, and they will be provided with the materials necessary to guide self-practice in HRV biofeedback at home. Participa...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Premenopausal (18-40 years)
- • Fluent in English
- • Heterosexual or bisexual
- • Score of 26.55 or less on the Female Sexual Function Index (FSFI)
- • Current sexual arousal dysfunction
- • Ownership of an Elite HRV compatible device (recent iPhone, iPad, or Android)
- Exclusion Criteria:
- • Pregnant or breastfeeding
- • History of or current sexually transmitted infections
- • History of major pelvic surgery
- • History of childhood sexual abuse
- • Currently taking androgens, estrogens, or other medical treatments to enhance sexual arousal
- • Current psychosis
- • If on antidepressants or antihypertensives, must be stabilized for at least 3 months
About University Of Texas At Austin
The University of Texas at Austin, a leading research institution, is dedicated to advancing knowledge and innovation in the field of healthcare through rigorous clinical trials. Known for its commitment to scientific excellence, the university leverages its diverse expertise and cutting-edge facilities to conduct research that addresses critical health challenges. Collaborating with a multidisciplinary team of researchers, clinicians, and students, the University of Texas at Austin aims to translate scientific discoveries into effective treatments and interventions, ultimately enhancing patient outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Austin, Texas, United States
Patients applied
Trial Officials
Cindy M Meston
Principal Investigator
The University of Texas at Austin
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials